The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Thye Dirk since 2023.
This trader's CIK number is 1638945.
At the time of last reporting, Thye Dirk was the CEO AND CHIEF MEDICAL OFFICER of Quince Therapeutics, Inc.. (stock ticker symbol QNCX).
Also see all insider trading activities at Quince Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | QNCX | 154,500 | $107,374 | 0 | $0 | 0 | $0 |
| 2023 | QNCX | 168,000 | $210,080 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-30 | QNCX | Buy | 77,000 | .70 | 53,900 |
| 2024-08-29 | QNCX | Buy | 77,500 | .69 | 53,474 |
| 2023-08-10 | QNCX | Buy | 88,000 | 1.26 | 110,880 |
| 2023-08-08 | QNCX | Buy | 80,000 | 1.24 | 99,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Thye Dirk (CEO AND CHIEF MEDICAL OFFICER of Quince Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.